首页> 外国专利> Combined product, method for producing a part kit, part kit, method of treating a condition, use of a combined product or part kit, and a melagatran and an xa factor inhibitor, or of a pharmaceutically acceptable derivative thereof

Combined product, method for producing a part kit, part kit, method of treating a condition, use of a combined product or part kit, and a melagatran and an xa factor inhibitor, or of a pharmaceutically acceptable derivative thereof

机译:组合产品,用于制备零件套件的方法,零件套件,治疗病症的方法,组合产品或零件套件的使用以及美拉加群和xa因子抑制剂或其药学上可接受的衍生物

摘要

"COMBINED PRODUCT, METHOD FOR PRODUCTION OF A PARTS KIT, PARTS KIT, CONDITION TREATMENT METHOD, USES OF A COMBINED PRODUCT OR PARTS KIT, AND A MELAGATRAN AND A XA FACTOR INHIBITOR, OR OF A PHARMACEUTICALLY ACCEPTABLE DERIVATIVE OF THE SAME ". there is provided a combined product comprising: (A) melagatran or a pharmaceutically acceptable derivative thereof; and (B) a Factor Xa inhibitor or a pharmaceutically acceptable derivative thereof, wherein each of components (A) and (B) is formulated in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, as well as the use of a such a product is combined in the treatment of a condition in which anticoagulant therapy is indicated.
机译:“组合产品,零件套件的生产方法,零件套件,状态处理方法,组合产品或零件套件的使用以及MELAGATRAN和XA因子抑制剂或同一药物的药物可接受的衍生物”。提供了一种组合产品,其包含:(A)美拉加群或其药学上可接受的衍生物; (B)因子Xa抑制剂或其药学上可接受的衍生物,其中将组分(A)和(B)中的每一种与药学上可接受的佐剂,稀释剂或载体混合配制,并使用此类产品在指示抗凝治疗的病症的治疗中联合使用“安乐死”。

著录项

  • 公开/公告号BR0111545A

    专利类型

  • 公开/公告日2003-07-01

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号BR20010111545

  • 发明设计人

    申请日2001-06-06

  • 分类号A61K38/55;A61P7/02;

  • 国家 BR

  • 入库时间 2022-08-22 00:03:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号